Skip to content
MedsAcross

Brand family

Iomervu

Iomeprol · Bracco Diagnostics
United States
Presentations
4
Markets
1

Iomervu is a brand of Iomeprol marketed by Bracco Diagnostics, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Iomeprol
Brand owner
Bracco Diagnostics
Registered in
United States
Strengths and forms
142800 mg/200 mL injection, 163200 mg/200 mL injection, 71400 mg/100 mL injection, 81600 mg/100 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Iomervu 142800 mg/200 mL injectionIntra-arterial, intravenousBracco DiagnosticsUS FDAAvailable on request
Iomervu 163200 mg/200 mL injectionIntra-arterial, intravenousBracco DiagnosticsUS FDAAvailable on request
Iomervu 71400 mg/100 mL injectionIntra-arterial, intravenousBracco DiagnosticsUS FDAAvailable on request
Iomervu 81600 mg/100 mL injectionIntra-arterial, intravenousBracco DiagnosticsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Iomervu

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.